C. Alba-delgado, Chronic pain leads to concomitant noradrenergic impairment and mood disorders, Biol. Psychiatry, vol.73, pp.54-62, 2013.

N. Attal, EFNS guidelines on pharmacological treatment of neuropathic pain, Eur. J. Neurol, vol.13, pp.1153-1169, 2006.

N. Attal, EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision, Eur. J. Neurol, vol.17, pp.1113-88, 2010.

N. Attal, The specific disease burden of neuropathic pain: results of a French nationwide survey, Pain, vol.152, pp.2836-2843, 2011.

P. J. Austin and G. Moalem-taylor, The neuro-immune balance in neuropathic pain: involvement of inflammatory immune cells, immune-like glial cells and cytokines, J. Neuroimmunol, vol.229, pp.26-50, 2011.

M. Barrot, Tests and models of nociception and pain in rodents, Neuroscience, vol.211, pp.39-50, 2012.

M. Barrot, From antidepressant drugs to beta-mimetics: preclinical insights on potential new treatments for neuropathic pain, Recent Pat. CNS Drug Discov, vol.4, pp.182-189, 2009.

M. Barrot, Antidepressant treatment of neuropathic pain: looking for the mechanism, Future Neurol, vol.5, pp.247-257, 2010.

M. Benbouzid, Chronic, but not acute, tricyclic antidepressant treatment alleviates neuropathic allodynia after sciatic nerve cuffing in mice, Eur. J. Pain, vol.12, pp.1008-1017, 2008.
URL : https://hal.archives-ouvertes.fr/hal-00343697

M. Benbouzid, Sciatic nerve cuffing in mice: a model of sustained neuropathic pain, Eur. J. Pain, vol.12, pp.591-599, 2008.
URL : https://hal.archives-ouvertes.fr/hal-00343709

Y. Bohren, Mu-opioid receptors are not necessary for nortriptyline treatment of neuropathic allodynia, Eur. J. Pain, vol.14, pp.700-704, 2010.

L. Cabal-hierro and P. S. Lazo, Signal transduction by tumor necrosis factor receptors, Cell. Signal, vol.24, pp.1297-1305, 2012.

N. Choucair-jaafar, Beta2-adrenoceptor agonists alleviate neuropathic allodynia in mice after chronic treatment, Br. J. Pharmacol, vol.158, pp.1683-1694, 2009.

N. Choucair-jaafar, Cardiovascular effects of chronic treatment with a ?2adrenoceptor agonist relieving neuropathic pain in mice, Neuropharmacology, vol.61, pp.51-60, 2011.

A. J. Chruscinski, Targeted disruption of the beta2 adrenergic receptor gene, J. Biol. Chem, vol.274, pp.16694-16700, 1999.

O. Y. Cok, Is there a place for beta-mimetics in clinical management of neuropathic pain? Salbutamol therapy in six cases, Anesthesiology, vol.112, pp.1276-1279, 2010.

R. H. Dworkin, Pharmacologic management of neuropathic pain: evidencebased recommendations, Pain, vol.132, pp.237-251, 2007.

M. El-mansari, Relevance of norepinephrine-dopamine interactions in the treatment of major depressive disorder, CNS Neurosci. Ther, vol.16, pp.1-17, 2010.

I. J. Elenkov, The sympathetic nerve-an integrative interface between two supersystems: the brain and the immune system, Pharmacol. Rev, vol.52, pp.595-638, 2000.

M. Empl, TNF-alpha expression in painful and nonpainful neuropathies, Neurology, vol.56, pp.1371-1377, 2001.

M. Hanani, Satellite glial cells in sensory ganglia: from form to function, Brain Res. Brain Res. Rev, vol.48, pp.457-476, 2005.

S. Hao, Gene transfer to interfere with TNFalpha signaling in neuropathic pain, Gene Ther, vol.14, pp.1010-1016, 2007.

E. Hetier, Modulation of interleukin-1 and tumor necrosis factor expression by beta-adrenergic agonists in mouse ameboid microglial cells, Exp. Brain Res, vol.86, pp.407-413, 1991.

C. Ho and M. E. O'leary, Single-cell analysis of sodium channel expression in dorsal root ganglion neurons, Mol. Cell. Neurosci, vol.46, pp.159-166, 2010.

T. S. Jensen, A new definition of neuropathic pain, Pain, vol.152, pp.2204-2205, 2011.

J. Kaufling, Pharmacological recruitment of the GABAergic tail of the ventral tegmental area by acute drug exposure, Br. J. Pharmacol, vol.161, pp.1677-1691, 2010.

T. Korhonen, The treatment of disc herniation-induced sciatica with infliximab: results of a randomized, controlled, 3-month follow-up study. Spine (Phila Pa 1976), vol.30, pp.2724-2728, 2005.

H. V. Krell, Evaluation of reboxetine, a noradrenergic antidepressant, for the treatment of fibromyalgia and chronic low back pain, Psychosomatics, vol.46, pp.379-384, 2005.

H. L. Lee, Temporal expression of cytokines and their receptors mRNAs in a neuropathic pain model, Neuroreport, vol.15, pp.2807-2811, 2004.

L. Leung and C. M. Cahill, TNF-alpha and neuropathic pain-a review, J. Neuroinflammation, vol.7, p.27, 2010.

T. Lindenlaub and C. Sommer, Cytokines in sural nerve biopsies from inflammatory and non-inflammatory neuropathies, Acta Neuropathol, vol.105, pp.593-602, 2003.

D. J. Macewan, TNF receptor subtype signalling: differences and cellular consequences, Cell. Signal, vol.14, pp.477-492, 2002.

P. W. Mantyh, Beta 2-adrenergic receptors are expressed by glia in vivo in the normal and injured central nervous system in the rat, rabbit, and human, J. Neurosci, vol.15, pp.152-164, 1995.

K. Maruo, Modulation of P2X receptors via adrenergic pathways in rat dorsal root ganglion neurons after sciatic nerve injury, Pain, vol.120, pp.106-112, 2006.

M. K. Mccoy and M. G. Tansey, TNF signaling inhibition in the CNS: implications for normal brain function and neurodegenerative disease, J. Neuroinflammation, vol.5, p.45, 2008.

E. M. Mclachlan, Peripheral nerve injury triggers noradrenergic sprouting within dorsal root ganglia, Nature, vol.363, pp.543-546, 1993.

J. A. Mico, Antidepressants and pain, Trends Pharmacol. Sci, vol.27, pp.348-354, 2006.

M. J. Millan, Descending control of pain, Prog. Neurobiol, vol.66, pp.355-474, 2002.

T. Mosconi and L. Kruger, Fixed-diameter polyethylene cuffs applied to the rat sciatic nerve induce a painful neuropathy: ultrastructural morphometric analysis of axonal alterations, Pain, vol.64, pp.37-57, 1996.

A. Nakamura, Regulation of tumour necrosis factor and interleukin-6 gene transcription by beta2-adrenoceptor in the rat astrocytes, J. Neuroimmunol, vol.88, pp.144-153, 1998.

A. Neil, Effects of guanethidine on sensitization to natural stimuli and selfmutilating behaviour in rats with a peripheral neuropathy, Brain Res, vol.565, pp.237-246, 1991.

X. M. Peng, Tumor necrosis factor-alpha contributes to below-level neuropathic pain after spinal cord injury, Ann. Neurol, vol.59, pp.843-851, 2006.

M. S. Ramer and M. A. Bisby, Normal and injury-induced sympathetic innervation of rat dorsal root ganglia increases with age, J. Comp. Neurol, vol.394, pp.38-47, 1998.

T. Saarto and P. J. Wiffen, Antidepressants for neuropathic pain, Cochrane Database Syst. Rev. CD005454, 2007.
URL : https://hal.archives-ouvertes.fr/hal-00557402

M. Santello and A. Volterra, TNFalpha in synaptic function: switching gears, Trends Neurosci, vol.35, pp.638-647, 2012.

B. Scallon, Binding and functional comparisons of two types of tumor necrosis factor antagonists, J. Pharmacol. Exp. Ther, vol.301, pp.418-426, 2002.

T. D. Schmittgen and B. A. Zakrajsek, Effect of experimental treatment on housekeeping gene expression: validation by real-time, quantitative RT-PCR, J. Biochem. Biophys. Methods, vol.46, pp.69-81, 2000.

A. Severn, Regulation of tumor necrosis factor production by adrenaline and beta-adrenergic agonists, J. Immunol, vol.148, pp.3441-3445, 1992.

C. Sommer, Anti-TNF-neutralizing antibodies reduce pain-related behavior in two different mouse models of painful mononeuropathy, Brain Res, vol.913, pp.86-89, 2001.

C. Sommer, Etanercept reduces hyperalgesia in experimental painful neuropathy, J. Peripher. Nerv. Syst, vol.6, pp.67-72, 2001.

T. Suzuki, Antiallodynic and antihyperalgesic effect of milnacipran in mice with spinal nerve ligation, Anesth. Analg, vol.106, pp.1309-1315, 2008.

J. Szelenyi, Differential involvement of sympathetic nervous system and immune system in the modulation of TNF-alpha production by alpha2-and betaadrenoceptors in mice, J. Neuroimmunol, vol.103, pp.34-40, 2000.

M. A. Thacker, Pathophysiology of peripheral neuropathic pain: immune cells and molecules, Anesth. Analg, vol.105, pp.838-847, 2007.

Y. Bohren, Neurobiology of Disease, vol.60, pp.39-50, 2013.

E. Tobinick and S. Davoodifar, Efficacy of etanercept delivered by perispinal administration for chronic back and/or neck disc-related pain: a study of clinical observations in 143 patients, Curr. Med. Res. Opin, vol.20, pp.1075-1085, 2004.

P. A. Trimmer, Combination of immunocytochemistry and radioligand receptor assay to identify beta-adrenergic receptor subtypes on astroglia in vitro, J. Neurosci, vol.4, pp.1598-1606, 1984.

N. Uceyler, Early cytokine expression in mouse sciatic nerve after chronic constriction nerve injury depends on calpain, Brain Behav. Immun, vol.21, pp.553-560, 2007.

R. Vallejo, Noradrenaline inhibits lipopolysaccharide-induced tumor necrosis factor and interleukin 6 production in human whole blood, Infect. Immun, vol.10, pp.2046-2050, 1994.

C. A. Von-hehn, Deconstructing the neuropathic pain phenotype to reveal neural mechanisms, Neuron, vol.73, pp.638-652, 2012.

R. Wagner and R. R. Myers, Endoneurial injection of TNF-alpha produces neuropathic pain behaviors, Neuroreport, vol.7, pp.2897-2901, 1996.

F. A. White, Chemokine signaling and the management of neuropathic pain, Mol. Interv, vol.9, pp.188-195, 2009.

I. Yalcin, Beta(2)-adrenoceptors are critical for antidepressant treatment of neuropathic pain, Ann. Neurol, vol.65, pp.218-225, 2009.
URL : https://hal.archives-ouvertes.fr/hal-00365815

I. Yalcin, Beta2-adrenoceptors are essential for desipramine, venlafaxine or reboxetine action in neuropathic pain, Neurobiol. Dis, vol.33, pp.386-394, 2009.
URL : https://hal.archives-ouvertes.fr/hal-00365807

I. Yalcin, Chronic treatment with agonists of beta(2)-adrenergic receptors in neuropathic pain, Exp. Neurol, vol.221, pp.115-121, 2010.

M. Yoshimura and H. Furue, Mechanisms for the anti-nociceptive actions of the descending noradrenergic and serotonergic systems in the spinal cord, J. Pharmacol. Sci, vol.101, pp.107-117, 2006.

Z. Zhou, A novel cell-cell signaling by microglial transmembrane TNFalpha with implications for neuropathic pain, Pain, vol.151, pp.296-306, 2010.

Y. Bohren, Neurobiology of Disease, vol.60, pp.39-50, 2013.

T. J. Allen, M. E. Cooper, and H. Y. Lan, Use of genetic mouse models in the study of diabetic nephropathy, Curr Diab Rep, vol.4, pp.435-440, 2004.

G. Andersen, K. Vestergaard, M. Ingeman-nielsen, and T. S. Jensen, Incidence of central post-stroke pain, Pain, vol.61, pp.187-193, 1995.

D. Ardid, A. Alloui, G. Brousse, J. D. Picard, P. Dubray et al., Potentiation of the antinociceptive effect of clomipramine by a 5-ht(1A) antagonist in neuropathic pain in rats, Br J Pharmacol, vol.132, pp.1118-1126, 2001.

A. Arsenault and J. Sawynok, Perisurgical amitriptyline produces a preventive effect on afferent hypersensitivity following spared nerve injury, Pain, vol.146, pp.308-314, 2009.

N. Attal, G. Cruccu, M. Haanpaa, P. Hansson, T. S. Jensen et al., EFNS guidelines on pharmacological treatment of neuropathic pain, Eur J Neurol, vol.13, pp.1153-1169, 2006.

N. Attal, C. Fermanian, J. Fermanian, M. Lanteri-minet, H. Alchaar et al., Neuropathic pain: are there distinct subtypes depending on the aetiology or anatomical lesion, Pain, vol.138, pp.343-353, 2008.
URL : https://hal.archives-ouvertes.fr/inserm-00292335

N. Attal, G. Cruccu, R. Baron, M. Haanpaa, P. Hansson et al., EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision, Eur J Neurol, vol.17, pp.1113-1188, 2010.

R. L. Aupperle, L. Ravindran, D. Tankersley, T. Flagan, N. R. Stein et al., Pregabalin influences insula and amygdala activation during anticipation of emotional images, Neuropsychopharmacology, vol.36, pp.1466-1477, 2011.

P. J. Austin and G. Moalem-taylor, The neuro-immune balance in neuropathic pain: involvement of inflammatory immune cells, immune-like glial cells and cytokines, J Neuroimmunol, vol.229, pp.26-50, 2010.

D. Baptista-de-souza, D. C. Mannelli, L. Zanardelli, M. Micheli, L. Nunes-de-souza et al., Serotonergic modulation in neuropathy induced by oxaliplatin: effect on the 5HT2C receptor, Eur J Pharmacol, vol.735, pp.141-149, 2014.

M. J. Barber, C. F. Starmer, and A. O. Grant, Blockade of cardiac sodium channels by amitriptyline and diphenylhydantoin. Evidence for two use-dependent binding sites, Circ Res, vol.69, pp.677-696, 1991.

R. Baron, Mechanisms of disease: neuropathic pain-a clinical perspective, Nat Clin Pract Neurol, vol.2, pp.95-106, 2006.

R. Baron, A. Binder, and G. Wasner, Neuropathic pain: diagnosis, pathophysiological mechanisms, and treatment, Lancet Neurol, vol.9, pp.807-819, 2010.

F. Barthas, J. Sellmeijer, S. Hugel, E. Waltisperger, M. Barrot et al., The anterior cingulate cortex is a critical hub for pain-induced depression, Biol Psychiatry, vol.77, pp.236-245, 2015.

C. S. Bauer, M. Nieto-rostro, W. Rahman, A. Tran-van-minh, L. Ferron et al., The increased trafficking of the calcium channel subunit alpha2delta-1 to presynaptic terminals in neuropathic pain is inhibited by the alpha2delta ligand pregabalin, J Neurosci, vol.29, pp.4076-4088, 2009.

L. A. Bee and A. H. Dickenson, Descending facilitation from the brainstem determines behavioural and neuronal hypersensitivity following nerve injury and efficacy of pregabalin, Pain, vol.140, pp.209-223, 2008.

M. Benbouzid, N. Choucair-jaafar, I. Yalcin, E. Waltisperger, A. Muller et al., Chronic, but not acute, tricyclic antidepressant treatment alleviates neuropathic allodynia after sciatic nerve cuffing in mice, Eur J Pain, vol.12, pp.1008-1017, 2008.
URL : https://hal.archives-ouvertes.fr/hal-00343697

M. Benbouzid, C. Gaveriaux-ruff, I. Yalcin, E. Waltisperger, L. H. Tessier et al., Delta-opioid receptors are critical for tricyclic antidepressant treatment of neuropathic allodynia, Biol Psychiatry, vol.63, pp.633-636, 2008.
URL : https://hal.archives-ouvertes.fr/hal-00343705

M. Benbouzid, V. Pallage, M. Rajalu, E. Waltisperger, S. Doridot et al., Sciatic nerve cuffing in mice: a model of sustained neuropathic pain, Eur J Pain, vol.12, pp.591-599, 2008.
URL : https://hal.archives-ouvertes.fr/hal-00343709

G. J. Bennett and Y. K. Xie, A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man, Pain, vol.33, pp.87-107, 1988.

M. Bennett, The LANSS Pain Scale: the Leeds assessment of neuropathic symptoms and signs, Pain, vol.92, pp.147-157, 2001.

M. I. Bennett, N. Attal, M. M. Backonja, R. Baron, D. Bouhassira et al., Using screening tools to identify neuropathic pain, Pain, vol.127, pp.199-203, 2007.

E. Berrocoso and J. A. Mico, In vivo effect of venlafaxine on locus coeruleus neurons: role of opioid, alpha(2)adrenergic, and 5-hydroxytryptamine(1A) receptors, J Pharmacol Exp Ther, vol.322, pp.101-107, 2007.

J. E. Biggs, P. A. Boakye, N. Ganesan, P. L. Stemkowski, A. Lantero et al., Analysis of the longterm actions of gabapentin and pregabalin in dorsal root ganglia and substantia gelatinosa, J Neurophysiol, vol.112, pp.2398-2412, 2014.

W. Binder, S. A. Mousa, N. Sitte, M. Kaiser, C. Stein et al., Sympathetic activation triggers endogenous opioid release and analgesia within peripheral inflamed tissue, Eur J Neurosci, vol.20, pp.92-100, 2004.
DOI : 10.1111/j.1460-9568.2004.03459.x

S. Blom, Trigeminal neuralgia: its treatment with a new anticonvulsant drug (G-32883), Lancet, vol.1, pp.839-840, 1962.

C. Bohm, D. Newrzella, S. Herberger, N. Schramm, G. Eisenhardt et al., Effects of antidepressant treatment on gene expression profile in mouse brain: cell type-specific transcription profiling using laser microdissection and microarray analysis, J Neurochem, vol.97, pp.44-49, 2006.

Y. Bohren, D. Karavelic, L. H. Tessier, I. Yalcin, C. Gaveriaux-ruff et al., Mu-opioid receptors are not necessary for nortriptyline treatment of neuropathic allodynia, Eur J Pain, vol.14, pp.700-704, 2010.

Y. Bohren, L. H. Tessier, S. Megat, H. Petitjean, S. Hugel et al., Antidepressants suppress neuropathic pain by a peripheral beta2adrenoceptor mediated anti-TNFalpha mechanism, Neurobiol Dis, vol.60, pp.39-50, 2013.
DOI : 10.1016/j.nbd.2013.08.012

S. F. Bomholt, J. D. Mikkelsen, and G. Blackburn-munro, Antinociceptive effects of the antidepressants amitriptyline, duloxetine, mirtazapine and citalopram in animal models of acute, persistent and neuropathic pain, Neuropharmacology, vol.48, pp.252-263, 2005.

H. Eutamene, A. M. Coelho, V. Theodorou, M. Toulouse, M. Chovet et al., Antinociceptive effect of pregabalin in septic shock-induced rectal hypersensitivity in rats, J Pharmacol Exp Ther, vol.295, pp.162-167, 2000.

M. J. Field, R. J. Oles, A. S. Lewis, S. Mccleary, J. Hughes et al., Gabapentin (neurontin) and S-(+)-3isobutylgaba represent a novel class of selective antihyperalgesic agents, Br J Pharmacol, vol.121, pp.1513-1522, 1997.
DOI : 10.1038/sj.bjp.0701320
URL : https://bpspubs.onlinelibrary.wiley.com/doi/pdf/10.1038/sj.bjp.0701320

M. J. Field, P. J. Cox, E. Stott, H. Melrose, J. Offord et al., Identification of the alpha2-delta-1 subunit of voltagedependent calcium channels as a molecular target for pain mediating the analgesic actions of pregabalin, Proc Natl Acad Sci U S A, vol.103, pp.17537-17542, 2006.

M. J. Field, Z. Li, and J. B. Schwarz, Ca2+ channel alpha2-delta ligands for the treatment of neuropathic pain, J Med Chem, vol.50, pp.2569-2575, 2007.

N. B. Finnerup, S. H. Sindrup, and T. S. Jensen, The evidence for pharmacological treatment of neuropathic pain, Pain, vol.150, pp.573-581, 2010.

N. B. Finnerup, N. Attal, S. Haroutounian, E. Mcnicol, R. Baron et al., Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis, Lancet Neurol, vol.14, pp.162-173, 2015.
DOI : 10.1016/j.jvs.2015.08.010

R. Freynhagen, R. Baron, U. Gockel, and T. R. Tolle, painDETECT: a new screening questionnaire to identify neuropathic components in patients with back pain, Curr Med Res Opin, vol.22, pp.1911-1920, 2006.
DOI : 10.1185/030079906x132488

F. B. Fukushima, G. A. Barros, M. E. Marques, E. I. Vidal, and E. M. Ganem, The neuraxial effects of intraspinal amitriptyline at low concentrations, Anesth Analg, vol.109, pp.965-971, 2009.

J. Gahimer, J. Wernicke, I. Yalcin, M. J. Ossanna, M. Wulster-radcliffe et al., A retrospective pooled analysis of duloxetine safety in 23,983 subjects, Curr Med Res Opin, vol.23, pp.175-184, 2007.

C. Gaveriaux-ruff and B. L. Kieffer, Opioid receptor genes inactivated in mice: the highlights, Neuropeptides, vol.36, pp.62-71, 2002.

N. S. Gee, J. P. Brown, V. U. Dissanayake, J. Offord, R. Thurlow et al., The novel anticonvulsant drug, gabapentin (Neurontin), binds to the alpha2delta subunit of a calcium channel, J Biol Chem, vol.271, pp.5768-5776, 1996.

P. Gerner, M. Mujtaba, C. J. Sinnott, and G. K. Wang, Amitriptyline versus bupivacaine in rat sciatic nerve blockade, Anesthesiology, vol.94, pp.661-667, 2001.

P. Gerner, M. Mujtaba, M. Khan, Y. Sudoh, K. Vlassakov et al., N-phenylethyl amitriptyline in rat sciatic nerve blockade, Anesthesiology, vol.96, pp.1435-1442, 2002.

P. Gerner, G. Kao, V. Srinivasa, S. Narang, and G. K. Wang, Topical amitriptyline in healthy volunteers, Reg Anesth Pain Med, vol.28, pp.289-293, 2003.

D. J. Goldstein, Y. Lu, M. J. Detke, T. C. Lee, and S. Iyengar, Duloxetine vs. placebo in patients with painful diabetic neuropathy, Pain, vol.116, pp.109-118, 2005.

L. Goncalves and A. H. Dickenson, Asymmetric time-dependent activation of right central amygdala neurones in rats with peripheral neuropathy and pregabalin modulation, Eur J Neurosci, vol.36, pp.3204-3213, 2012.

M. Haanpaa, N. Attal, M. Backonja, R. Baron, M. Bennett et al., Pain, vol.152, pp.14-27, 2011.

V. Hajhashemi, H. R. Banafshe, M. Minaiyan, A. Mesdaghinia, and A. Abed, Antinociceptive effects of venlafaxine in a rat model of peripheral neuropathy: role of alpha2-adrenergic receptors, Eur J Pharmacol, vol.738, pp.230-236, 2014.

J. E. Hammack, J. C. Michalak, C. L. Loprinzi, J. A. Sloan, P. J. Novotny et al., Phase III evaluation of nortriptyline for alleviation of symptoms of cis-platinum-induced peripheral neuropathy, Pain, vol.98, pp.195-203, 2002.

M. Hamon, H. Gozlan, S. Bourgoin, J. J. Benoliel, A. Mauborgne et al., Opioid receptors and neuropeptides in the CNS in rats treated chronically with amoxapine or amitriptyline, Neuropharmacology, vol.26, pp.531-539, 1987.

R. E. Harris, V. Napadow, J. P. Huggins, L. Pauer, J. Kim et al., Pregabalin rectifies aberrant brain chemistry, connectivity, and functional response in chronic pain patients, Anesthesiology, vol.119, pp.1453-1464, 2013.

K. Hayashida, S. Degoes, R. Curry, and J. C. Eisenach, Gabapentin activates spinal noradrenergic activity in rats and humans and reduces hypersensitivity after surgery, Anesthesiology, vol.106, pp.557-562, 2007.

K. Hayashida, H. Obata, K. Nakajima, and J. C. Eisenach, Gabapentin acts within the locus coeruleus to alleviate neuropathic pain, Anesthesiology, vol.109, pp.1077-1084, 2008.

R. Patel, C. S. Bauer, M. Nieto-rostro, W. Margas, L. Ferron et al., gene deletion affects somatosensory neuron function and delays mechanical hypersensitivity in response to peripheral nerve damage, J Neurosci, vol.33, pp.16412-16426, 2013.

D. G. Perahia, Y. L. Pritchett, D. Desaiah, and J. Raskin, Efficacy of duloxetine in painful symptoms: an analgesic or antidepressant effect?, Int Clin Psychopharmacol, vol.21, pp.311-317, 2006.

X. Pichon, A. S. Wattiez, C. Becamel, I. Ehrlich, J. Bockaert et al., Disrupting 5HT(2A) receptor/PDZ protein interactions reduces hyperalgesia and enhances SSRI efficacy in neuropathic pain, Mol Ther, vol.18, pp.1462-1470, 2010.

R. C. Polomano, A. J. Mannes, U. S. Clark, and G. J. Bennett, A painful peripheral neuropathy in the rat produced by the chemotherapeutic drug, paclitaxel. Pain, vol.94, pp.293-304, 2001.

R. Portenoy, Development and testing of a neuropathic pain screening questionnaire: ID Pain, Curr Med Res Opin, vol.22, pp.1555-1565, 2006.

S. A. Prescott, Synaptic inhibition and disinhibition in the spinal dorsal horn, Prog Mol Biol Transl Sci, vol.131, pp.359-383, 2015.

C. Qu, T. King, A. Okun, J. Lai, H. L. Fields et al., Lesion of the rostral anterior cingulate cortex eliminates the aversiveness of spontaneous neuropathic pain following partial or complete axotomy, Pain, vol.152, pp.1641-1648, 2011.

F. Radat, A. Margot-duclot, and N. Attal, Psychiatric co-morbidities in patients with chronic peripheral neuropathic pain: a multicentre cohort study, Eur J Pain, vol.17, pp.1547-1557, 2013.

M. S. Ramer and M. A. Bisby, Normal and injury-induced sympathetic innervation of rat dorsal root ganglia increases with age, J Comp Neurol, vol.394, pp.38-47, 1998.

T. Rantamaki and I. Yalcin, Antidepressant drug action-From rapid changes on network function to network rewiring, Prog Neuropsychopharmacol Biol Psychiatry, vol.64, pp.285-292, 2016.

I. J. Reynolds and R. J. Miller, Tricyclic antidepressants block N-methyl-D-aspartate receptors: similarities to the action of zinc, Br J Pharmacol, vol.95, pp.95-102, 1988.

F. Rode, T. Brolos, G. Blackburn-munro, and O. J. Bjerrum, Venlafaxine compromises the antinociceptive actions of gabapentin in rat models of neuropathic and persistent pain, Psychopharmacology (Berl), vol.187, pp.364-375, 2006.

S. P. Roose, Considerations for the use of antidepressants in patients with cardiovascular disease, Am Heart J, vol.140, pp.84-88, 2000.

M. C. Rowbotham, L. A. Reisner, P. S. Davies, and H. L. Fields, Treatment response in antidepressant-naive postherpetic neuralgia patients: double-blind, randomized trial, J Pain, vol.6, pp.741-746, 2005.

T. Ruyang, Z. Yang, and F. Wei, Gabapentin prevents oxaliplatin-induced central sensitization in the dorsal horn neurons in rats, Iran J Basic Med Sci, vol.18, pp.493-498, 2015.

T. Saarto and P. J. Wiffen, Antidepressants for neuropathic pain, Cochrane Database Syst Rev CD005454, 2007.
URL : https://hal.archives-ouvertes.fr/hal-00557402

H. Sada, N. Egashira, S. Ushio, T. Kawashiri, M. Shirahama et al., Repeated administration of amitriptyline reduces oxaliplatin-induced mechanical allodynia in rats, J Pharmacol Sci, vol.118, pp.547-551, 2012.

F. Saika, N. Kiguchi, Y. Kobayashi, Y. Fukazawa, T. Maeda et al., Suppressive effect of imipramine on vincristine-induced mechanical allodynia in mice, Biol Pharm Bull, vol.32, pp.1231-1234, 2009.

Z. Seltzer, R. Dubner, and Y. Shir, A novel behavioral model of neuropathic pain disorders produced in rats by partial sciatic nerve injury, Pain, vol.43, pp.205-218, 1990.

M. R. Semenchuk, S. Sherman, and B. Davis, Double-blind, randomized trial of bupropion SR for the treatment of neuropathic pain, Neurology, vol.57, pp.1583-1588, 2001.

J. Serra, H. Bostock, R. Sola, J. Aleu, E. Garcia et al., Microneurographic identification of spontaneous activity in C-nociceptors in neuropathic pain states in humans and rats, Pain, vol.153, pp.42-55, 2012.

S. H. Sindrup, L. F. Gram, K. Brosen, O. Eshoj, and E. F. Mogensen, The selective serotonin reuptake inhibitor paroxetine is effective in the treatment of diabetic neuropathy symptoms, Pain, vol.42, pp.135-144, 1990.

S. H. Sindrup, U. Bjerre, A. Dejgaard, K. Brosen, T. Aaes-jorgensen et al., The selective serotonin reuptake inhibitor citalopram relieves the symptoms of diabetic neuropathy, Clin Pharmacol Ther, vol.52, pp.547-552, 1992.

S. H. Sindrup and T. S. Jensen, Pharmacotherapy of trigeminal neuralgia, Clin J Pain, vol.18, pp.22-27, 2002.

S. H. Sindrup, M. Otto, N. B. Finnerup, and T. S. Jensen, Antidepressants in the treatment of neuropathic pain, Basic Clin Pharmacol Toxicol, vol.96, pp.399-409, 2005.

L. S. Sorkin, W. H. Xiao, R. Wagner, and R. R. Myers, Tumour necrosis factor-alpha induces ectopic activity in nociceptive primary afferent fibres, Neuroscience, vol.81, pp.255-262, 1997.

M. Stratinaki, A. Varidaki, V. Mitsi, S. Ghose, J. Magida et al., Regulator of G protein signaling 4 [corrected] is a crucial modulator of References 1, Pain, vol.152, pp.2204-2205, 2011.

C. A. Von-hehn, B. R. Woolf, and C. J. , Deconstructing the neuropathic pain phenotype to reveal neural mechanisms, Neuron, vol.73, pp.638-652, 2012.

N. B. Finnerup, N. Attal, and S. Haroutounian, Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis, Lancet Neurol, vol.14, pp.162-173, 2015.

C. Lanneau, A. Green, and W. D. Hirst, Gabapentin is not a GABAB receptor agonist, Neuropharmacology, vol.41, pp.965-975, 2001.

J. A. Mico and R. Prieto, Elucidating the mechanism of action of pregabalin: alpha(2)delta as a therapeutic target in anxiety, CNS Drugs, vol.26, pp.637-648, 2012.

M. J. Field, P. J. Cox, and E. Stott, Identification of the alpha2delta-1 subunit of voltage-dependent calcium channels as a molecular target for pain mediating the analgesic actions of pregabalin, Proc Natl Acad Sci, vol.103, pp.17537-17542, 2006.

N. S. Gee, J. P. Brown, and V. U. Dissanayake, The novel anticonvulsant drug

R. Publiés,

C. Alba-delgado, J. A. Mico, P. Sanchez-blazquez, and E. Berrocoso, Analgesic antidepressants promote the responsiveness of locus coeruleus neurons to noxious stimulation: implications for neuropathic pain, Pain, vol.153, pp.1438-1449, 2012.

C. Alba-delgado, M. Llorca-torralba, I. Horrillo, J. E. Ortega, J. A. Mico et al., Chronic pain leads to concomitant noradrenergic impairment and mood disorders, Biol Psychiatry, vol.73, pp.54-62, 2013.

T. J. Allen, M. E. Cooper, and H. Y. Lan, Use of genetic mouse models in the study of diabetic nephropathy, Curr Diab Rep, vol.4, pp.435-440, 2004.

R. Amir, C. E. Argoff, G. J. Bennett, T. R. Cummins, M. E. Durieux et al., The role of sodium channels in chronic inflammatory and neuropathic pain, J Pain, vol.7, pp.1-29, 2006.

S. Anders, P. T. Pyl, and W. Huber, HTSeq-a Python framework to work with high-throughput sequencing data, Bioinformatics, vol.31, pp.166-169, 2015.

D. Ardid and G. Guilbaud, Antinociceptive effects of acute and 'chronic' injections of tricyclic antidepressant drugs in a new model of mononeuropathy in rats, Pain, vol.49, pp.279-287, 1992.

D. Ardid, J. D. Mestre, C. Villanueva, L. , L. Bars et al., Involvement of bulbospinal pathways in the antinociceptive effect of clomipramine in the rat, Brain Res, vol.695, pp.253-256, 1995.

A. Arsenault and J. Sawynok, Perisurgical amitriptyline produces a preventive effect on afferent hypersensitivity following spared nerve injury, Pain, vol.146, pp.308-314, 2009.

N. Attal, G. Cruccu, M. Haanpaa, P. Hansson, T. S. Jensen et al., EFNS guidelines on pharmacological treatment of neuropathic pain, Eur J Neurol, vol.13, pp.1153-1169, 2006.

N. Attal, G. Cruccu, R. Baron, M. Haanpaa, P. Hansson et al., EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision, Eur J Neurol, vol.17, pp.1113-1188, 2010.

C. Baastrup, T. S. Jensen, and N. B. Finnerup, Pregabalin attenuates place escape/avoidance behavior in a rat model of spinal cord injury, Brain Res, vol.1370, pp.129-135, 2011.

Y. H. Bao, Q. H. Zhou, R. Chen, H. Xu, L. L. Zeng et al., Gabapentin enhances the morphine anti-nociceptive effect in neuropathic pain via the interleukin-10-heme oxygenase1 signalling pathway in rats, J Mol Neurosci, vol.54, pp.137-146, 2014.

R. Baron, Mechanisms of disease: neuropathic pain-a clinical perspective, Nat Clin Pract Neurol, vol.2, pp.95-106, 2006.

M. Barrot, I. Yalcin, N. Choucair-jaafar, M. Benbouzid, and M. J. Freund-mercier, From antidepressant drugs to beta-mimetics: preclinical insights on potential new treatments for neuropathic pain, Recent Pat CNS Drug Discov, vol.4, pp.182-189, 2009.

M. Barrot, Tests and models of nociception and pain in rodents, Neuroscience, vol.211, pp.39-50, 2012.

F. Barthas, J. Sellmeijer, S. Hugel, E. Waltisperger, M. Barrot et al., The anterior cingulate cortex is a critical hub for pain-induced depression, Biol Psychiatry, vol.77, pp.236-245, 2015.

D. L. Bellinger and D. Lorton, Autonomic regulation of cellular immune function, Auton Neurosci, vol.182, pp.15-41, 2014.

G. J. Bennett and Y. K. Xie, A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man, Pain, vol.33, pp.87-107, 1988.

O. G. Berge, Predictive validity of behavioural animal models for chronic pain, Br J Pharmacol, vol.164, pp.1195-1206, 2011.

J. D. Berry and K. L. Petersen, A single dose of gabapentin reduces acute pain and allodynia in patients with herpes zoster, Neurology, vol.65, pp.444-447, 2005.

T. Berta, T. Liu, Y. C. Liu, Z. Z. Xu, and R. R. Ji, Acute morphine activates satellite glial cells and up-regulates IL-1beta in dorsal root ganglia in mice via matrix metalloprotease-9, Mol Pain, vol.8, p.18, 2012.

G. Blackburn-munro and H. K. Erichsen, Antiepileptics and the treatment of neuropathic pain: evidence from animal models, Curr Pharm Des, vol.11, pp.2961-2976, 2005.

N. Blume, J. Leonard, Z. J. Xu, O. Watanabe, H. Remotti et al., Characterization of Cyp2d22, a novel cytochrome P450 expressed in mouse mammary cells, Arch Biochem Biophys, vol.381, pp.191-204, 2000.

J. J. Bogaards, M. Bertrand, P. Jackson, M. J. Oudshoorn, R. J. Weaver et al., Determining the best animal model for human cytochrome P450 activities: a comparison of mouse, rat, rabbit, dog, micropig, monkey and man, Xenobiotica, vol.30, pp.1131-1152, 2000.

Y. Bohren, L. H. Tessier, S. Megat, H. Petitjean, S. Hugel et al., Antidepressants suppress neuropathic pain by a peripheral beta2-adrenoceptor mediated anti-TNFalpha mechanism, Neurobiol Dis, vol.60, pp.39-50, 2013.

A. M. Bolger, M. Lohse, and B. Usadel, Trimmomatic: a flexible trimmer for Illumina sequence data, Bioinformatics, vol.30, pp.2114-2120, 2014.

U. Bongenhielm, F. M. Boissonade, A. Westermark, P. P. Robinson, and K. Fried, Sympathetic nerve sprouting fails to occur in the trigeminal ganglion after peripheral nerve injury in the rat, Pain, vol.82, pp.283-288, 1999.

D. Bouhassira, M. Lanteri-minet, N. Attal, B. Laurent, and C. Touboul, Prevalence of chronic pain with neuropathic characteristics in the general population, Pain, vol.136, pp.380-387, 2008.
URL : https://hal.archives-ouvertes.fr/inserm-00326893

S. Bourane, B. Duan, S. C. Koch, A. Dalet, O. Britz et al., Gate control of mechanical itch by a subpopulation of spinal cord interneurons, Science, vol.350, pp.550-554, 2015.

L. Bravo, J. A. Mico, R. Rey-brea, B. Perez-nievas, J. C. Leza et al., Depressive-like states heighten the aversion to painful stimuli in a rat model of comorbid chronic pain and depression, Anesthesiology, vol.117, pp.613-625, 2012.

L. Bravo, S. Torres-sanchez, A. , C. Mico, J. A. Berrocoso et al., Pain exacerbates chronic mild stress-induced changes in noradrenergic transmission in rats, Eur Neuropsychopharmacol, vol.24, pp.996-1003, 2014.

V. Brazda, I. Klusakova, I. Svizenska, Z. Veselkova, and P. Dubovy, Bilateral changes in IL-6 protein, but not in its receptor gp130, in rat dorsal root ganglia following sciatic nerve ligature, Cell Mol Neurobiol, vol.29, pp.1053-1062, 2009.

K. L. Brewer and R. P. Yezierski, Effects of adrenal medullary transplants on pain-related behaviors following excitotoxic spinal cord injury, Brain Res, vol.798, pp.83-92, 1998.

M. Busch-dienstfertig and C. Stein, Opioid receptors and opioid peptide-producing leukocytes in inflammatory pain-basic and therapeutic aspects, Brain Behav Immun, vol.24, pp.683-694, 2010.

B. J. Caldarone, K. Karthigeyan, A. Harrist, J. G. Hunsberger, E. Wittmack et al., Sex differences in response to oral amitriptyline in three animal models of depression in C57BL/6J mice, Psychopharmacology (Berl), vol.170, pp.94-101, 2003.

M. Calvo, J. M. Dawes, and D. L. Bennett, The role of the immune system in the generation of neuropathic pain, Lancet Neurol, vol.11, pp.629-642, 2012.

C. C. Camara, H. F. Ramos, A. P. Da-silva, C. V. Araujo, A. S. Gomes et al., Oral gabapentin treatment accentuates nerve and peripheral inflammatory responses following experimental nerve constriction in Wistar rats, Neurosci Lett, vol.556, pp.93-98, 2013.

W. M. Campana, Schwann cells: activated peripheral glia and their role in neuropathic pain, Brain Behav Immun, vol.21, pp.522-527, 2007.

F. G. Campbell, J. G. Graham, and K. J. Zilkha, Clinical trial of carbazepine (tegretol) in trigeminal neuralgia, J Neurol Neurosurg Psychiatry, vol.29, pp.265-267, 1966.

T. T. Cao, A. Brelot, and M. Von-zastrow, The composition of the beta-2 adrenergic receptor oligomer affects its membrane trafficking after ligand-induced endocytosis, Mol Pharmacol, vol.67, pp.288-297, 2005.

D. D. Cardenas and E. R. Felix, Pain after spinal cord injury: a review of classification, treatment approaches, and treatment assessment, PM R, vol.1, pp.1077-1090, 2009.

R. M. Carnahan, B. C. Lund, P. J. Perry, B. G. Pollock, and K. R. Culp, The Anticholinergic Drug Scale as a measure of drug-related anticholinergic burden: associations with serum anticholinergic activity, J Clin Pharmacol, vol.46, pp.1481-1486, 2006.

K. Cegielska-perun, M. Bujalska-zadrozny, J. Tatarkiewicz, E. Gasinska, and M. He, Venlafaxine and neuropathic pain, Pharmacology, vol.91, pp.69-76, 2013.

L. E. Chaparro, P. J. Wiffen, R. A. Moore, and I. Gilron, Combination pharmacotherapy for the treatment of neuropathic pain in adults, Cochrane Database Syst Rev, vol.7, p.8943, 2012.

S. Chattopadhyay and V. I. Shubayev, MMP-9 controls Schwann cell proliferation and phenotypic remodeling via IGF-1 and ErbB receptor-mediated activation of MEK/ERK pathway, Glia, vol.57, pp.1316-1325, 2009.

N. Choucair-jaafar, I. Yalcin, J. L. Rodeau, E. Waltisperger, M. J. Freund-mercier et al., Beta2adrenoceptor agonists alleviate neuropathic allodynia in mice after chronic treatment, Br J Pharmacol, vol.158, pp.1683-1694, 2009.

N. Choucair-jaafar, E. Salvat, M. J. Freund-mercier, and M. Barrot, The antiallodynic action of nortriptyline and terbutaline is mediated by beta(2) adrenoceptors and delta opioid receptors in the ob/ob model of diabetic polyneuropathy, Brain Res, vol.1546, pp.18-26, 2014.

A. J. Chruscinski, D. K. Rohrer, E. Schauble, K. H. Desai, D. Bernstein et al., Targeted disruption of the beta2 adrenergic receptor gene, J Biol Chem, vol.274, pp.16694-16700, 1999.

T. J. Coderre, N. Kumar, C. D. Lefebvre, and J. S. Yu, Evidence that gabapentin reduces neuropathic pain by inhibiting the spinal release of glutamate, J Neurochem, vol.94, pp.1131-1139, 2005.

S. P. Cohen, D. Wenzell, R. W. Hurley, C. Kurihara, C. C. Buckenmaier et al., A double-blind, placebo-controlled, dose-response pilot study evaluating intradiscal etanercept in patients with chronic discogenic low back pain or lumbosacral radiculopathy, Anesthesiology, vol.107, pp.99-105, 2007.

O. Y. Cok, H. E. Eker, I. Yalcin, M. Barrot, and A. Aribogan, Is there a place for beta-mimetics in clinical management of neuropathic pain? Salbutamol therapy in six cases, Anesthesiology, vol.112, pp.1276-1279, 2010.

J. A. Coull, D. Boudreau, K. Bachand, S. A. Prescott, F. Nault et al., Transsynaptic shift in anion gradient in spinal lamina I neurons as a mechanism of neuropathic pain, Nature, vol.424, pp.938-942, 2003.

J. A. Coull, S. Beggs, D. Boudreau, D. Boivin, M. Tsuda et al., BDNF from microglia causes the shift in neuronal anion gradient underlying neuropathic pain, Nature, vol.438, pp.1017-1021, 2005.

G. Cruccu, N. B. Finnerup, T. S. Jensen, J. Scholz, M. Sindou et al., Trigeminal neuralgia: New classification and diagnostic grading for practice and research, 2016.

B. M. Davis, H. S. Wang, K. M. Albers, S. L. Carlson, T. P. Goodness et al., Effects of NGF overexpression on anatomical and physiological properties of sympathetic postganglionic neurons, Brain Res, vol.724, pp.47-54, 1996.

O. De-la, M. Arciniega, M. I. Diaz-reval, A. R. Cortes-arroyo, A. M. Dominguez-ramirez et al., Anti-nociceptive synergism of morphine and gabapentin in neuropathic pain induced by chronic constriction injury, Pharmacol Biochem Behav, vol.92, pp.457-464, 2009.

I. Decosterd and C. J. Woolf, Spared nerve injury: an animal model of persistent peripheral neuropathic pain, Pain, vol.87, pp.149-158, 2000.

P. Dharmshaktu, V. Tayal, and B. S. Kalra, Efficacy of antidepressants as analgesics: a review, J Clin Pharmacol, vol.52, pp.6-17, 2012.

J. M. Dias, T. V. Brito, D. De-aguiar-magalhaes, S. Da, P. W. Santos et al., Gabapentin, a synthetic analogue of gamma aminobutyric acid, reverses systemic acute inflammation and oxidative stress in mice, Inflammation, vol.37, pp.1826-1836, 2014.

A. Dierich and B. L. Kieffer, Knockout mouse models in pain research, Methods Mol Med, vol.99, pp.269-299, 2004.

O. A. Dina, C. A. Parada, J. Yeh, X. Chen, G. C. Mccarter et al., Integrin signaling in inflammatory and neuropathic pain in the rat, Eur J Neurosci, vol.19, pp.634-642, 2004.

A. Dolphin, J. L. Noebels, A. M. Rogawski, M. A. Olsen, and R. W. , Calcium channel alpha2delta subunits in epilepsy and as targets for antiepileptic drugs, National Center for Biotechnology Information (US), 2012.

Z. Dou, Z. Jiang, and J. Zhong, Efficacy and safety of pregabalin in patients with neuropathic cancer pain undergoing morphine therapy, Asia Pac J Clin Oncol, 2014.

P. Dubovy, I. Klusakova, I. Svizenska, and V. Brazda, Satellite glial cells express IL-6 and corresponding signal-transducing receptors in the dorsal root ganglia of rat neuropathic pain model, Neuron Glia Biol, vol.6, pp.73-83, 2010.

P. Dubovy, V. Brazda, I. Klusakova, and I. Hradilova-svizenska, Bilateral elevation of interleukin-6 protein and mRNA in both lumbar and cervical dorsal root ganglia following unilateral chronic compression injury of the sciatic nerve, J Neuroinflammation, vol.10, p.55, 2013.

C. H. Duman and R. S. Duman, Spine synapse remodeling in the pathophysiology and treatment of depression, Neurosci Lett, vol.601, pp.20-29, 2015.

R. S. Duman, Pathophysiology of depression: the concept of synaptic plasticity, Eur Psychiatry, vol.17, pp.306-310, 2002.

R. H. Dworkin, D. C. Turk, J. T. Farrar, J. A. Haythornthwaite, M. P. Jensen et al., Core outcome measures for chronic pain clinical trials: IMMPACT recommendations. Pain, vol.113, pp.9-19, 2005.

R. H. Dworkin, O. Connor, A. B. Backonja, M. Farrar, J. T. Finnerup et al., Pharmacologic management of neuropathic pain: evidence-based recommendations, Pain, vol.132, pp.237-251, 2007.

M. El-mansari, B. P. Guiard, O. Chernoloz, R. Ghanbari, N. Katz et al., Relevance of norepinephrine-dopamine interactions in the treatment of major depressive disorder, CNS Neurosci Ther, vol.16, pp.1-17, 2010.

I. J. Elenkov, R. L. Wilder, G. P. Chrousos, and E. S. Vizi, The sympathetic nerve-an integrative interface between two supersystems: the brain and the immune system, Pharmacol Rev, vol.52, pp.595-638, 2000.

M. Empl, S. Renaud, B. Erne, P. Fuhr, A. Straube et al., TNF-alpha expression in painful and nonpainful neuropathies, Neurology, vol.56, pp.1371-1377, 2001.
DOI : 10.1212/wnl.56.10.1371

T. Endoh, H. Matsuura, C. Tanaka, and H. Nagase, Nor-binaltorphimine: a potent and selective kappaopioid receptor antagonist with long-lasting activity in vivo, Arch Int Pharmacodyn Ther, vol.316, pp.30-42, 1992.

P. Farmer and J. Pugin, beta-adrenergic agonists exert their "anti-inflammatory" effects in monocytic cells through the IkappaB/NF-kappaB pathway, Am J Physiol Lung Cell Mol Physiol, vol.279, pp.675-682, 2000.

W. T. Farmer, T. Abrahamsson, S. Chierzi, C. Lui, C. Zaelzer et al., Neurons diversify astrocytes in the adult brain through sonic hedgehog signaling, Science, vol.351, pp.849-854, 2016.

M. J. Field, P. J. Cox, E. Stott, H. Melrose, J. Offord et al., Identification of the alpha2delta-1 subunit of voltage-dependent calcium channels as a molecular target for pain mediating the analgesic actions of pregabalin, Proc Natl Acad Sci U S A, vol.103, pp.17537-17542, 2006.

H. L. Fields, Treatment of trigeminal neuralgia, N Engl J Med, vol.334, pp.1125-1126, 1996.

D. Filliol, S. Ghozland, J. Chluba, M. Martin, H. W. Matthes et al., Mice deficient for delta-and muopioid receptors exhibit opposing alterations of emotional responses, Nat Genet, vol.25, pp.195-200, 2000.

N. B. Finnerup, N. Attal, S. Haroutounian, E. Mcnicol, R. Baron et al., Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis, Lancet Neurol, vol.14, pp.162-173, 2015.

D. A. Fishbain, R. Cutler, H. L. Rosomoff, and R. S. Rosomoff, Evidence-based data from animal and human experimental studies on pain relief with antidepressants: a structured review, Pain Med, vol.1, pp.310-316, 2000.
DOI : 10.1046/j.1526-4637.2000.00042.x
URL : https://academic.oup.com/painmedicine/article-pdf/1/4/310/5238198/1-4-310.pdf

K. Fisher, M. E. Fundytus, C. M. Cahill, and T. J. Coderre, Intrathecal administration of the mGluR compound, (S)-4CPG, attenuates hyperalgesia and allodynia associated with sciatic nerve constriction injury in rats, Pain, vol.77, pp.59-66, 1998.

C. Gaveriaux-ruff and B. L. Kieffer, Opioid receptor genes inactivated in mice: the highlights, Neuropeptides, vol.36, pp.62-71, 2002.

V. Gavrilyuk, D. Russo, C. Heneka, M. T. Pelligrino, D. Weinberg et al., Norepinephrine increases I kappa B alpha expression in astrocytes, J Biol Chem, vol.277, pp.29662-29668, 2002.

L. Gendron, N. Mittal, H. Beaudry, and W. Walwyn, Recent advances on the delta opioid receptor: from trafficking to function, Br J Pharmacol, vol.172, pp.403-419, 2015.

C. Ghelardini, N. Galeotti, and A. Bartolini, Antinociception induced by amitriptyline and imipramine is mediated by alpha2A-adrenoceptors, Jpn J Pharmacol, vol.82, pp.130-137, 2000.
DOI : 10.1254/jjp.82.130
URL : https://www.jstage.jst.go.jp/article/jjp/82/2/82_2_130/_pdf

R. Ginzburg and Z. Seltzer, Subarachnoid spinal cord transplantation of adrenal medulla suppresses chronic neuropathic pain behavior in rats, Brain Res, vol.523, pp.147-150, 1990.

N. Giroux, S. Rossignol, and T. A. Reader, Autoradiographic study of alpha1-and alpha2-noradrenergic and serotonin1A receptors in the spinal cord of normal and chronically transected cats, J Comp Neurol, vol.406, pp.402-414, 1999.

P. Goupille, D. Mulleman, G. Paintaud, H. Watier, and J. P. Valat, Can sciatica induced by disc herniation be treated with tumor necrosis factor alpha blockade?, Arthritis Rheum, vol.56, pp.3887-3895, 2007.

A. M. Gray, P. S. Spencer, and R. D. Sewell, The involvement of the opioidergic system in the antinociceptive mechanism of action of antidepressant compounds, Br J Pharmacol, vol.124, pp.669-674, 1998.

N. S. Gregory, A. L. Harris, C. R. Robinson, P. M. Dougherty, P. N. Fuchs et al., An overview of animal models of pain: disease models and outcome measures, J Pain, vol.14, pp.1255-1269, 2013.

Y. Gueguen, K. Mouzat, L. Ferrari, E. Tissandie, J. M. Lobaccaro et al., Cytochromes P450: xenobiotic metabolism, regulation and clinical importance, Ann Biol Clin, vol.64, pp.535-548, 2006.

A. Hama and J. Sagen, Behavioral characterization and effect of clinical drugs in a rat model of pain following spinal cord compression, Brain Res, vol.1185, pp.117-128, 2007.

A. T. Hama and J. Sagen, Reduced pain-related behavior by adrenal medullary transplants in rats with experimental painful peripheral neuropathy, Pain, vol.52, pp.223-231, 1993.

M. Hanani, Satellite glial cells in sensory ganglia: from form to function, Brain Res Brain Res Rev, vol.48, pp.457-476, 2005.

J. Handa, M. Sekiguchi, O. Krupkova, and S. Konno, The effect of serotonin-noradrenaline reuptake inhibitor duloxetine on the intervertebral disk-related radiculopathy in rats, Eur Spine J, vol.25, pp.877-887, 2016.

P. Hansson, Difficulties in stratifying neuropathic pain by mechanisms, Eur J Pain, vol.7, pp.353-357, 2003.

S. Hatashita, M. Sekiguchi, H. Kobayashi, S. Konno, and S. Kikuchi, Contralateral neuropathic pain and neuropathology in dorsal root ganglion and spinal cord following hemilateral nerve injury in rats, Spine, vol.33, pp.1344-1351, 1976.

K. Hayashida, B. A. Clayton, J. E. Johnson, and J. C. Eisenach, Brain derived nerve growth factor induces spinal noradrenergic fiber sprouting and enhances clonidine analgesia following nerve injury in rats, Pain, vol.136, pp.348-355, 2008.

A. Hervera, S. Leanez, R. Negrete, R. Motterlini, and O. Pol, Carbon monoxide reduces neuropathic pain and spinal microglial activation by inhibiting nitric oxide synthesis in mice, PLoS One, vol.7, p.43693, 2012.
URL : https://hal.archives-ouvertes.fr/inserm-00746573

K. D. Hoffmann and M. A. Matthews, Comparison of sympathetic neurons in orofacial and upper extremity nerves: implications for causalgia, J Oral Maxillofac Surg, vol.48, pp.720-726, 1990.

S. V. Holdridge and C. M. Cahill, Spinal administration of a delta opioid receptor agonist attenuates hyperalgesia and allodynia in a rat model of neuropathic pain, Eur J Pain, vol.11, pp.685-693, 2007.

T. Horiuchi, H. Mitoma, S. Harashima, H. Tsukamoto, and T. Shimoda, Transmembrane TNF-alpha: structure, function and interaction with anti-TNF agents, Rheumatology (Oxford), vol.49, pp.1215-1228, 2010.

P. Hu and E. M. Mclachlan, Macrophage and lymphocyte invasion of dorsal root ganglia after peripheral nerve lesions in the rat, Neuroscience, vol.112, pp.23-38, 2002.

S. Hughes, L. Hickey, L. F. Donaldson, B. M. Lumb, and A. E. Pickering, Intrathecal reboxetine suppresses evoked and ongoing neuropathic pain behaviours by restoring spinal noradrenergic inhibitory tone, Pain, vol.156, pp.328-334, 2015.

J. Hwang, L. T. Zheng, J. Ock, M. G. Lee, S. H. Kim et al., Inhibition of glial inflammatory activation and neurotoxicity by tricyclic antidepressants, Neuropharmacology, vol.55, pp.826-834, 2008.

J. H. Hwang and T. L. Yaksh, Effect of subarachnoid gabapentin on tactile-evoked allodynia in a surgically induced neuropathic pain model in the rat, Reg Anesth, vol.22, pp.249-256, 1997.

J. Izumi, M. Washizuka, Y. Hayashi-kuwabara, K. Yoshinaga, Y. Tanaka et al., Evidence for a depressive-like state induced by repeated saline injections in Fischer 344 rats, Pharmacol Biochem Behav, vol.57, pp.883-888, 1997.

R. Jancalek, I. Svizenska, I. Klusakova, and P. Dubovy, Bilateral changes of IL-10 protein in lumbar and cervical dorsal root ganglia following proximal and distal chronic constriction injury of peripheral nerve, Neurosci Lett, vol.501, pp.86-91, 2011.

W. Janig, Sympathetic nervous system and inflammation: a conceptual view, Auton Neurosci, vol.182, pp.4-14, 2014.

S. Javed, Q. U. Kamili, N. Mendoza, and S. K. Tyring, Possible association of lower rate of postherpetic neuralgia in patients on anti-tumor necrosis factor-alpha, J Med Virol, vol.83, pp.2051-2055, 2011.

T. S. Jensen, R. Baron, M. Haanpaa, E. Kalso, J. D. Loeser et al., A new definition of neuropathic pain, Pain, vol.152, pp.2204-2205, 2011.

R. R. Ji, Z. Z. Xu, X. Wang, and E. H. Lo, Matrix metalloprotease regulation of neuropathic pain, Trends Pharmacol Sci, vol.30, pp.336-340, 2009.

B. A. Jordan, N. Trapaidze, I. Gomes, R. Nivarthi, and L. A. Devi, Oligomerization of opioid receptors with beta 2-adrenergic receptors: a role in trafficking and mitogen-activated protein kinase activation, Proc Natl Acad Sci U S A, vol.98, pp.343-348, 2001.

N. Kabli and C. M. Cahill, Anti-allodynic effects of peripheral delta opioid receptors in neuropathic pain, Pain, vol.127, pp.84-93, 2007.

B. Kaltschmidt and C. Kaltschmidt, NF-kappaB in the nervous system, Cold Spring Harb Perspect Biol, vol.1, p.1271, 2009.

S. Katsuyama, K. Sato, T. Yagi, Y. Kishikawa, and H. Nakamura, Effects of repeated milnacipran and fluvoxamine treatment on mechanical allodynia in a mouse paclitaxel-induced neuropathic pain model, Biomed Res, vol.34, pp.105-111, 2013.

J. Kaufling, E. Waltisperger, R. Bourdy, A. Valera, P. Veinante et al., Pharmacological recruitment of the GABAergic tail of the ventral tegmental area by acute drug exposure, Br J Pharmacol, vol.161, pp.1677-1691, 2010.

Y. Kawasaki, Z. Z. Xu, X. Wang, J. Y. Park, Z. Y. Zhuang et al., Distinct roles of matrix metalloproteases in the early-and late-phase development of neuropathic pain, Nat Med, vol.14, pp.331-336, 2008.

B. Kaygisiz, F. S. Kilic, N. Senguleroglu, C. Baydemir, and K. Erol, The antinociceptive effect and mechanisms of action of pregabalin in mice, Pharmacol Rep, vol.67, pp.129-133, 2015.

A. F. Keller, S. Beggs, M. W. Salter, D. Koninck, and Y. , Transformation of the output of spinal lamina I neurons after nerve injury and microglia stimulation underlying neuropathic pain, Mol Pain, vol.3, p.27, 2007.

J. Khan, H. Alghamdi, M. M. Anwer, E. Eliav, and V. Ziccardi, Role of Collagen Conduit With Duloxetine and/or Pregabalin in the Management of Partial Peripheral Nerve Injury, J Oral Maxillofac Surg, vol.74, pp.1120-1130, 2016.

C. F. Kim and G. Moalem-taylor, Detailed characterization of neuro-immune responses following neuropathic injury in mice, Brain Res, vol.1405, pp.95-108, 2011.

S. H. Kim and J. M. Chung, An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat, Pain, vol.50, pp.355-363, 1992.

T. King, C. Qu, A. Okun, R. Mercado, J. Ren et al., Contribution of afferent pathways to nerve injury-induced spontaneous pain and evoked hypersensitivity, Pain, vol.152, pp.1997-2005, 2011.

A. G. Kippenberger, D. J. Palmer, A. M. Comer, J. Lipski, L. D. Burton et al., Localization of the noradrenaline transporter in rat adrenal medulla and PC12 cells: evidence for its association with secretory granules in PC12 cells, J Neurochem, vol.73, pp.1024-1032, 1999.

M. P. Knadler, E. Lobo, J. Chappell, and R. Bergstrom, Duloxetine: clinical pharmacokinetics and drug interactions, Clin Pharmacokinet, vol.50, pp.281-294, 2011.

H. V. Krell, A. F. Leuchter, I. A. Cook, and M. Abrams, Evaluation of reboxetine, a noradrenergic antidepressant, for the treatment of fibromyalgia and chronic low back pain, Psychosomatics, vol.46, pp.379-384, 2005.

M. Kremer, I. Yalcin, L. Nexon, X. Wurtz, R. A. Ceredig et al., The antiallodynic action of pregabalin in neuropathic pain is independent from the opioid system, Mol Pain, vol.12, p.1744806916636387, 2016.

R. Kusuda, M. I. Ravanelli, F. Cadetti, A. Franciosi, K. Previdelli et al., Long-term antidepressant treatment inhibits neuropathic pain-induced CREB and PLCgamma-1 phosphorylation in the mouse spinal cord dorsal horn, J Pain, vol.14, pp.1162-1172, 2013.

A. J. Kwilasz, P. M. Grace, P. Serbedzija, S. F. Maier, and L. R. Watkins, The therapeutic potential of interleukin-10 in neuroimmune diseases, Neuropharmacology, vol.96, pp.55-69, 2015.

R. J. Lantz, T. A. Gillespie, T. J. Rash, F. Kuo, M. Skinner et al., Metabolism, excretion, and pharmacokinetics of duloxetine in healthy human subjects, Drug Metab Dispos, vol.31, pp.1142-1150, 2003.

L. Cudennec, C. Castagne, and V. , Face-to-face comparison of the predictive validity of two models of neuropathic pain in the rat: analgesic activity of pregabalin, tramadol and duloxetine, Eur J Pharmacol, vol.735, pp.17-25, 2014.

A. Ledeboer, M. Gamanos, W. Lai, D. Martin, S. F. Maier et al., Involvement of spinal cord nuclear factor kappaB activation in rat models of proinflammatory cytokine-mediated pain facilitation, Eur J Neurosci, vol.22, pp.1977-1986, 2005.

A. Ledeboer, B. M. Jekich, E. M. Sloane, J. H. Mahoney, S. J. Langer et al., Intrathecal interleukin-10 gene therapy attenuates paclitaxel-induced mechanical allodynia and proinflammatory cytokine expression in dorsal root ganglia in rats, Brain Behav Immun, vol.21, pp.686-698, 2007.

B. S. Lee, I. G. Jun, S. H. Kim, and J. Y. Park, Intrathecal gabapentin increases interleukin-10 expression and inhibits pro-inflammatory cytokine in a rat model of neuropathic pain, J Korean Med Sci, vol.28, pp.308-314, 2013.

H. L. Lee, K. M. Lee, S. J. Son, S. H. Hwang, and H. J. Cho, Temporal expression of cytokines and their receptors mRNAs in a neuropathic pain model, Neuroreport, vol.15, pp.2807-2811, 2004.

K. M. Lee, S. M. Jeon, and H. J. Cho, Tumor necrosis factor receptor 1 induces interleukin-6 upregulation through NF-kappaB in a rat neuropathic pain model, Eur J Pain, vol.13, pp.794-806, 2009.

T. S. Lee and L. Y. Chau, Heme oxygenase-1 mediates the anti-inflammatory effect of interleukin-10 in mice, Nat Med, vol.8, pp.240-246, 2002.

L. Leung and C. M. Cahill, TNF-alpha and neuropathic pain-a review, J Neuroinflammation, vol.7, p.27, 2010.

Z. Li, C. P. Taylor, M. Weber, J. Piechan, F. Prior et al., Pregabalin is a potent and selective ligand for alpha(2)delta-1 and alpha(2)delta-2 calcium channel subunits, Eur J Pharmacol, vol.667, pp.80-90, 2011.

H. Y. Lin, W. L. Yeh, B. R. Huang, C. Lin, C. H. Lai et al., Desipramine protects neuronal cell death and induces heme oxygenase-1 expression in Mes23.5 dopaminergic neurons, PLoS One, vol.7, p.50138, 2012.

M. Llorca-torralba, G. Borges, F. Neto, J. A. Mico, and E. Berrocoso, Noradrenergic Locus Coeruleus pathways in pain modulation, 2016.

J. D. Loeser and R. D. Treede, The Kyoto protocol of IASP Basic Pain Terminology, Pain, vol.137, pp.473-477, 2008.

M. I. Love, W. Huber, and S. Anders, Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2, Genome Biol, vol.15, p.550, 2014.

X. Lu and P. M. Richardson, Responses of macrophages in rat dorsal root ganglia following peripheral nerve injury, J Neurocytol, vol.22, pp.334-341, 1993.

J. Ludwig, A. Binder, J. Steinmann, G. Wasner, and R. Baron, Cytokine expression in serum and cerebrospinal fluid in non-inflammatory polyneuropathies, J Neurol Neurosurg Psychiatry, vol.79, pp.1268-1273, 2008.

M. S. Luer, C. Hamani, M. Dujovny, B. Gidal, M. Cwik et al., Saturable transport of gabapentin at the blood-brain barrier, Neurol Res, vol.21, pp.559-562, 1999.

W. Ma and J. C. Eisenach, Chronic constriction injury of sciatic nerve induces the up-regulation of descending inhibitory noradrenergic innervation to the lumbar dorsal horn of mice, Brain Res, vol.970, pp.110-118, 2003.

S. S. Makarov, NF-kappaB as a therapeutic target in chronic inflammation: recent advances, Mol Med Today, vol.6, pp.441-448, 2000.

P. W. Mantyh, S. D. Rogers, C. J. Allen, M. D. Catton, J. R. Ghilardi et al., Beta 2adrenergic receptors are expressed by glia in vivo in the normal and injured central nervous system in the rat, rabbit, and human, J Neurosci, vol.15, pp.152-164, 1995.

F. Marchand, D. Ardid, E. Chapuy, A. Alloui, D. Jourdan et al., Evidence for an involvement of supraspinal delta-and spinal mu-opioid receptors in the antihyperalgesic effect of chronically administered clomipramine in mononeuropathic rats, J Pharmacol Exp Ther, vol.307, pp.268-274, 2003.

F. Marchand, M. Perretti, and S. B. Mcmahon, Role of the immune system in chronic pain, Nat Rev Neurosci, vol.6, pp.521-532, 2005.

F. Marchand, C. Tsantoulas, D. Singh, J. Grist, A. K. Clark et al., Effects of Etanercept and Minocycline in a rat model of spinal cord injury, Eur J Pain, vol.13, pp.673-681, 2009.

K. Maruo, H. Yamamoto, S. Yamamoto, T. Nagata, H. Fujikawa et al., Modulation of P2X receptors via adrenergic pathways in rat dorsal root ganglion neurons after sciatic nerve injury, Pain, vol.120, pp.106-112, 2006.

M. Matsumoto, M. Inoue, A. Hald, W. Xie, and H. Ueda, Inhibition of paclitaxel-induced A-fiber hypersensitization by gabapentin, J Pharmacol Exp Ther, vol.318, pp.735-740, 2006.

R. Matsuzawa, T. Fujiwara, K. Nemoto, T. Fukushima, S. Yamaguchi et al., Presynaptic inhibitory actions of pregabalin on excitatory transmission in superficial dorsal horn of mouse spinal cord: further characterization of presynaptic mechanisms, Neurosci Lett, vol.558, pp.186-191, 2014.

H. W. Matthes, R. Maldonado, F. Simonin, O. Valverde, S. Slowe et al., Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the mu-opioid-receptor gene, Nature, vol.383, pp.819-823, 1996.

G. Maussion, A. B. Diallo, C. O. Gigek, E. S. Chen, L. Crapper et al., Investigation of genes important in neurodevelopment disorders in adult human brain, Hum Genet, vol.134, pp.1037-1053, 2015.

E. M. Mclachlan, W. Janig, M. Devor, and M. Michaelis, Peripheral nerve injury triggers noradrenergic sprouting within dorsal root ganglia, Nature, vol.363, pp.543-546, 1993.

S. Megat, Y. Bohren, S. Doridot, C. Gaveriaux-ruff, B. L. Kieffer et al., ) kappa-Opioid receptors are not necessary for the antidepressant treatment of neuropathic pain, Br J Pharmacol, vol.172, pp.1034-1044, 2015.

F. Mennicken, J. Zhang, C. Hoffert, S. Ahmad, A. Beaudet et al., Phylogenetic changes in the expression of delta opioid receptors in spinal cord and dorsal root ganglia, J Comp Neurol, vol.465, pp.349-360, 2003.

J. A. Mico, D. Ardid, E. Berrocoso, and A. Eschalier, Antidepressants and pain, Trends Pharmacol Sci, vol.27, pp.348-354, 2006.

J. A. Mico and R. Prieto, Elucidating the mechanism of action of pregabalin: alpha(2)delta as a therapeutic target in anxiety, CNS Drugs, vol.26, pp.637-648, 2012.

E. D. Milligan, K. R. Penzkover, R. G. Soderquist, and M. J. Mahoney, Spinal interleukin-10 therapy to treat peripheral neuropathic pain, Neuromodulation, vol.15, pp.520-526, 2012.

H. F. Miranda, F. Sierralta, S. Lux, R. Troncoso, N. Ciudad et al., Involvement of nitridergic and opioidergic pathways in the antinociception of gabapentin in the orofacial formalin test in mice, Pharmacol Rep, vol.67, pp.399-403, 2015.

J. S. Mogil, L. Yu, and A. I. Basbaum, Pain genes?: natural variation and transgenic mutants, Annu Rev Neurosci, vol.23, pp.777-811, 2000.

N. Morin, S. A. Owolabi, M. W. Harty, E. F. Papa, T. F. Tracy et al., Neutrophils invade lumbar dorsal root ganglia after chronic constriction injury of the sciatic nerve, J Neuroimmunol, vol.184, pp.164-171, 2007.

T. Nakamura, T. Ikeda, R. Takeda, K. Igawa, R. Naono-nakayama et al., The role of spinal serotonin receptor and alpha adrenoceptor on the antiallodynic effects induced by intrathecal milnacipran in chronic constriction injury rats, Eur J Pharmacol, vol.738, pp.57-65, 2014.

F. P. Nascimento, C. Magnussen, N. Yousefpour, and A. Ribeiro-da-silva, Sympathetic fibre sprouting in the skin contributes to pain-related behaviour in spared nerve injury and cuff models of neuropathic pain, Mol Pain, vol.11, p.59, 2015.

W. T. Norton, D. A. Aquino, I. Hozumi, F. C. Chiu, and C. F. Brosnan, Quantitative aspects of reactive gliosis: a review, Neurochem Res, vol.17, pp.877-885, 1992.

S. Ohtori, K. Takahashi, H. Moriya, and R. R. Myers, TNF-alpha and TNF-alpha receptor type 1 upregulation in glia and neurons after peripheral nerve injury: studies in murine DRG and spinal cord, Spine, vol.29, pp.1082-1088, 1976.

E. A. Old, A. K. Clark, and M. Malcangio, The role of glia in the spinal cord in neuropathic and inflammatory pain, Handb Exp Pharmacol, vol.227, pp.145-170, 2015.

S. M. Opal and V. A. Depalo, Anti-inflammatory cytokines, Chest, vol.117, pp.1162-1172, 2000.

U. K. Ozdogan, J. Lahdesmaki, H. Mansikka, and M. Scheinin, Loss of amitriptyline analgesia in alpha 2A-adrenoceptor deficient mice, Eur J Pharmacol, vol.485, pp.193-196, 2004.

F. Paoli, G. Darcourt, and P. Cossa, , 1960.

, Rev Neurol (Paris), vol.102, pp.503-504

R. Patel and A. H. Dickenson, Mechanisms of the gabapentinoids and alpha 2 delta-1 calcium channel subunit in neuropathic pain, Pharmacol Res Perspect, vol.4, p.205, 2016.

D. G. Perahia, Y. L. Pritchett, D. Desaiah, and J. Raskin, Efficacy of duloxetine in painful symptoms: an analgesic or antidepressant effect?, Int Clin Psychopharmacol, vol.21, pp.311-317, 2006.

A. Pertovaara, Noradrenergic pain modulation, Prog Neurobiol, vol.80, pp.53-83, 2006.

A. Pertovaara, The noradrenergic pain regulation system: a potential target for pain therapy, Eur J Pharmacol, vol.716, pp.2-7, 2013.

G. M. Pitcher, J. Ritchie, and J. L. Henry, Paw withdrawal threshold in the von Frey hair test is influenced by the surface on which the rat stands, J Neurosci Methods, vol.87, pp.185-193, 1999.

G. M. Pitcher and J. L. Henry, Cellular mechanisms of hyperalgesia and spontaneous pain in a spinalized rat model of peripheral neuropathy: changes in myelinated afferent inputs implicated, Eur J Neurosci, vol.12, pp.2006-2020, 2000.

G. M. Pitcher and J. L. Henry, Nociceptive response to innocuous mechanical stimulation is mediated via myelinated afferents and NK-1 receptor activation in a rat model of neuropathic pain, Exp Neurol, vol.186, pp.173-197, 2004.

B. G. Pollock, B. H. Mulsant, R. Nebes, M. A. Kirshner, A. E. Begley et al., Serum anticholinergicity in elderly depressed patients treated with paroxetine or nortriptyline, Am J Psychiatry, vol.3, pp.1110-1112, 1998.

S. Pullar and A. M. Palmer, Pharmacotherapy for neuropathic pain: progress and prospects, Drug News Perspect, vol.16, pp.622-630, 2003.

M. S. Ramer and M. A. Bisby, Normal and injury-induced sympathetic innervation of rat dorsal root ganglia increases with age, J Comp Neurol, vol.394, pp.38-47, 1998.

M. S. Ramer and M. A. Bisby, Adrenergic innervation of rat sensory ganglia following proximal or distal painful sciatic neuropathy: distinct mechanisms revealed by anti-NGF treatment, Eur J Neurosci, vol.11, pp.837-846, 1999.

D. Ramsay, E. Kellett, M. Mcvey, S. Rees, and G. Milligan, Homo-and hetero-oligomeric interactions between G-protein-coupled receptors in living cells monitored by two variants of bioluminescence resonance energy transfer (BRET): hetero-oligomers between receptor subtypes form more efficiently than between less closely related sequences, Biochem J, vol.365, pp.429-440, 2002.

T. Rantamaki and I. Yalcin, Antidepressant drug action-From rapid changes on network function to network rewiring, Prog Neuropsychopharmacol Biol Psychiatry, vol.64, pp.285-292, 2016.

A. S. Rice, D. Cimino-brown, J. C. Eisenach, V. K. Kontinen, M. L. Lacroix-fralish et al., Animal models and the prediction of efficacy in clinical trials of analgesic drugs: a critical appraisal and call for uniform reporting standards, Pain, vol.139, pp.243-247, 2008.

F. Rodieux, V. Piguet, P. Berney, J. Desmeules, and M. Besson, Prescription of antidepressants in the treatment of pain: role of pharmacogenetics, Rev Med Suisse, vol.11, pp.1374-1379, 2015.

A. O. Rosa, J. Egea, S. Lorrio, A. I. Rojo, A. Cuadrado et al., Nrf2-mediated haeme oxygenase-1 up-regulation induced by cobalt protoporphyrin has antinociceptive effects against inflammatory pain in the formalin test in mice, Pain, vol.137, pp.332-339, 2008.

T. Saarto and P. J. Wiffen, Antidepressants for neuropathic pain, Cochrane Database Syst Rev CD005454, 2007.
URL : https://hal.archives-ouvertes.fr/hal-00557402

P. Sacerdote, S. Franchi, A. E. Trovato, A. E. Valsecchi, A. E. Panerai et al., Transient early expression of TNF-alpha in sciatic nerve and dorsal root ganglia in a mouse model of painful peripheral neuropathy, Neurosci Lett, vol.436, pp.210-213, 2008.

F. Saika, N. Kiguchi, Y. Kobayashi, Y. Fukazawa, T. Maeda et al., Suppressive effect of imipramine on vincristine-induced mechanical allodynia in mice, Biol Pharm Bull, vol.32, pp.1231-1234, 2009.

E. Salvat, B. Schweitzer, G. Massard, N. Meyer, F. De-blay et al., Effects of beta2 agonists on post-thoracotomy pain incidence, Eur J Pain, vol.19, pp.1428-1436, 2015.

M. Sandelin, S. Zabihi, L. Liu, G. Wicher, and E. N. Kozlova, Metastasis-associated S100A4 (Mts1) protein is expressed in subpopulations of sensory and autonomic neurons and in Schwann cells of the adult rat, J Comp Neurol, vol.473, pp.233-243, 2004.

A. Sasaki, K. Serizawa, T. Andoh, K. Shiraki, H. Takahata et al., Pharmacological differences between static and dynamic allodynia in mice with herpetic or postherpetic pain, J Pharmacol Sci, vol.108, pp.266-273, 2008.

B. Scallon, A. Cai, N. Solowski, A. Rosenberg, X. Y. Song et al., Binding and functional comparisons of two types of tumor necrosis factor antagonists, J Pharmacol Exp Ther, vol.301, pp.418-426, 2002.

G. Scherrer, N. Imamachi, Y. Q. Cao, C. Contet, F. Mennicken et al., Dissociation of the opioid receptor mechanisms that control mechanical and heat pain, Cell, vol.137, pp.1148-1159, 2009.
URL : https://hal.archives-ouvertes.fr/inserm-00420156

S. Schreiber, M. M. Backer, and C. G. Pick, The antinociceptive effect of venlafaxine in mice is mediated through opioid and adrenergic mechanisms, Neurosci Lett, vol.273, pp.85-88, 1999.

Z. Seltzer, R. Dubner, and Y. Shir, A novel behavioral model of neuropathic pain disorders produced in rats by partial sciatic nerve injury, Pain, vol.43, pp.205-218, 1990.

P. Senthamil-selvan, K. V. Gowda, U. Mandal, S. Solomon, W. D. Pal et al., Determination of duloxetine in human plasma by liquid chromatography with atmospheric pressure ionizationtandem mass spectrometry and its application to pharmacokinetic study, J Chromatogr B Analyt Technol Biomed Life Sci, vol.858, pp.269-275, 2007.

U. Sharma, T. Griesing, B. Emir, and J. P. Young, Time to onset of neuropathic pain reduction: A retrospective analysis of data from nine controlled trials of pregabalin for painful diabetic peripheral neuropathy and postherpetic neuralgia, Am J Ther, vol.17, pp.577-585, 2010.

V. Shinder, R. Govrin-lippmann, S. Cohen, M. Belenky, P. Ilin et al., Structural basis of sympathetic-sensory coupling in rat and human dorsal root ganglia following peripheral nerve injury, J Neurocytol, vol.28, pp.743-761, 1999.

S. A. Shore and P. E. Moore, Regulation of beta-adrenergic responses in airway smooth muscle, Respir Physiol Neurobiol, vol.137, pp.179-195, 2003.

J. B. Siegan and J. Sagen, Adrenal medullary transplants attenuate sensorimotor dysfunction in rats with peripheral neuropathy, Pharmacol Biochem Behav, vol.59, pp.97-104, 1998.

F. Simonin, O. Valverde, C. Smadja, S. Slowe, I. Kitchen et al., Disruption of the kappa-opioid receptor gene in mice enhances sensitivity to chemical visceral pain, impairs pharmacological actions of the selective kappa-agonist U50,488H and attenuates morphine withdrawal, EMBO J, vol.17, pp.886-897, 1998.

S. H. Sindrup, M. Otto, N. B. Finnerup, and T. S. Jensen, Antidepressants in the treatment of neuropathic pain, Basic Clin Pharmacol Toxicol, vol.96, pp.399-409, 2005.

C. Sommer and M. Schafers, Painful mononeuropathy in C57BL/Wld mice with delayed wallerian degeneration: differential effects of cytokine production and nerve regeneration on thermal and mechanical hypersensitivity, Brain Res, vol.784, pp.154-162, 1998.

X. J. Song, Z. J. Huang, W. B. Song, X. S. Song, A. F. Fuhr et al., Attenuation Effect of Spinal Manipulation on Neuropathic and Postoperative Pain Through Activating Endogenous Anti-Inflammatory Cytokine Interleukin 10 in Rat Spinal Cord, J Manipulative Physiol Ther, vol.39, pp.42-53, 2016.

R. E. Sorge, J. C. Mapplebeck, S. Rosen, S. Beggs, S. Taves et al., Different immune cells mediate mechanical pain hypersensitivity in male and female mice, Nat Neurosci, vol.18, pp.1081-1083, 2015.

K. Spiegel, R. Kalb, and G. W. Pasternak, Analgesic activity of tricyclic antidepressants, Ann Neurol, vol.13, pp.462-465, 1983.

A. A. Steiner, L. G. Branco, F. Q. Cunha, and S. H. Ferreira, Role of the haeme oxygenase/carbon monoxide pathway in mechanical nociceptor hypersensitivity, Br J Pharmacol, vol.132, pp.1673-1682, 2001.

B. H. Stewart, A. R. Kugler, P. R. Thompson, and H. N. Bockbrader, A saturable transport mechanism in the intestinal absorption of gabapentin is the underlying cause of the lack of proportionality between increasing dose and drug levels in plasma, Pharm Res, vol.10, pp.276-281, 1993.

W. J. Streit, S. A. Walter, and N. A. Pennell, Reactive microgliosis, Prog Neurobiol, vol.57, pp.563-581, 1999.

T. Suzuki, K. Ueta, S. Tamagaki, and T. Mashimo, Antiallodynic and antihyperalgesic effect of milnacipran in mice with spinal nerve ligation, Anesth Analg, vol.106, pp.1309-1315, 2008.

Y. H. Tai, R. Y. Tsai, S. L. Lin, C. C. Yeh, J. J. Wang et al., Amitriptyline suppresses neuroinflammation-dependent interleukin-10-p38 mitogen-activated protein kinase-heme oxygenase-1 signaling pathway in chronic morphine-infused rats, Anesthesiology, vol.110, pp.1379-1389, 2009.

N. Takahashi, T. Tetsuka, H. Uranishi, and T. Okamoto, Inhibition of the NF-kappaB transcriptional activity by protein kinase A, Eur J Biochem, vol.269, pp.4559-4565, 2002.

M. Takeda, T. Tanimoto, J. Kadoi, M. Nasu, M. Takahashi et al., Enhanced excitability of nociceptive trigeminal ganglion neurons by satellite glial cytokine following peripheral inflammation, Pain, vol.129, pp.155-166, 2007.

Y. Takeuchi, K. Takasu, M. Honda, H. Ono, and M. Tanabe, Neurochemical evidence that supraspinally administered gabapentin activates the descending noradrenergic system after peripheral nerve injury, Eur J Pharmacol, vol.556, pp.69-74, 2007.

Y. Takeuchi, K. Takasu, H. Ono, and M. Tanabe, Pregabalin, S-(+)-3-isobutylgaba, activates the descending noradrenergic system to alleviate neuropathic pain in the mouse partial sciatic nerve ligation model, Neuropharmacology, vol.53, pp.842-853, 2007.

M. Tanabe, K. Takasu, N. Kasuya, S. Shimizu, M. Honda et al., Role of descending noradrenergic system and spinal alpha2-adrenergic receptors in the effects of gabapentin on thermal and mechanical nociception after partial nerve injury in the mouse, Br J Pharmacol, vol.144, pp.703-714, 2005.

M. Tanabe, K. Takasu, Y. Takeuchi, and H. Ono, Pain relief by gabapentin and pregabalin via supraspinal mechanisms after peripheral nerve injury, J Neurosci Res, vol.86, pp.3258-3264, 2008.

O. Tatti, E. Gucciardo, P. Pekkonen, T. Holopainen, R. Louhimo et al., MMP16 Mediates a Proteolytic Switch to Promote Cell-Cell Adhesion, Collagen Alignment, and Lymphatic Invasion in Melanoma, Cancer Res, vol.75, pp.2083-2094, 2015.

D. K. Thakor, A. Lin, Y. Matsuka, E. M. Meyer, S. Ruangsri et al., Increased peripheral nerve excitability and local NaV1.8 mRNA up-regulation in painful neuropathy, Mol Pain, vol.5, p.14, 2009.

K. Thibault, B. Elisabeth, D. Sophie, F. Z. Claude, R. Bernard et al., Antinociceptive and antiallodynic effects of oral PL37, a complete inhibitor of enkephalin-catabolizing enzymes, in a rat model of peripheral neuropathic pain induced by vincristine, Eur J Pharmacol, vol.600, pp.71-77, 2008.

T. Trang, S. Beggs, and M. W. Salter, Purinoceptors in microglia and neuropathic pain, Pflugers Arch, vol.452, pp.645-652, 2006.

C. Trapnell, L. Pachter, and S. L. Salzberg, TopHat: discovering splice junctions with RNA-Seq, Bioinformatics, vol.25, pp.1105-1111, 2009.

P. A. Trimmer, T. Evans, M. M. Smith, T. K. Harden, and K. D. Mccarthy, Combination of immunocytochemistry and radioligand receptor assay to identify beta-adrenergic receptor subtypes on astroglia in vitro, J Neurosci, vol.4, pp.1598-1606, 1984.

M. Tsuda, Y. Shigemoto-mogami, S. Koizumi, A. Mizokoshi, S. Kohsaka et al., P2X4 receptors induced in spinal microglia gate tactile allodynia after nerve injury, Nature, vol.424, pp.778-783, 2003.

U. I. Ucel, O. D. Can, D. Ozkay, U. Ozturk, and Y. , Antihyperalgesic and antiallodynic effects of mianserin on diabetic neuropathic pain: a study on mechanism of action, Eur J Pharmacol, vol.756, pp.92-106, 2015.

N. Uceyler, J. P. Rogausch, K. V. Toyka, and C. Sommer, Differential expression of cytokines in painful and painless neuropathies, Neurology, vol.69, pp.42-49, 2007.

O. Valverde, J. A. Mico, R. Maldonado, M. Mellado, and J. Gibert-rahola, Participation of opioid and monoaminergic mechanisms on the antinociceptive effect induced by tricyclic antidepressants in two behavioural pain tests in mice, Prog Neuropsychopharmacol Biol Psychiatry, vol.18, pp.1073-1092, 1994.

P. P. Van-lumig, S. P. Menting, J. M. Van-den-reek, P. I. Spuls, P. L. Van-riel et al., An increased risk of non-melanoma skin cancer during TNF-inhibitor treatment in psoriasis patients compared to rheumatoid arthritis patients probably relates to disease-related factors, J Eur Acad Dermatol Venereol, vol.29, pp.752-760, 2015.

V. Vialou, J. Feng, A. J. Robison, and E. J. Nestler, Epigenetic mechanisms of depression and antidepressant action, Annu Rev Pharmacol Toxicol, vol.53, pp.59-87, 2013.

H. Viisanen and A. Pertovaara, Influence of peripheral nerve injury on response properties of locus coeruleus neurons and coeruleospinal antinociception in the rat, Neuroscience, vol.146, pp.1785-1794, 2007.

G. S. Walsh and M. D. Kawaja, Sympathetic axons surround nerve growth factor-immunoreactive trigeminal neurons: observations in mice overexpressing nerve growth factor, J Neurobiol, vol.34, pp.347-360, 1998.

H. Wang, X. T. Li, C. Wu, Z. W. Wu, Y. Y. Li et al., ) miR-132 can inhibit glioma cells invasion and migration by target MMP16 in vitro, Onco Targets Ther, vol.8, pp.3211-3218, 2015.

H. B. Wang, B. Zhao, Y. Q. Zhong, K. C. Li, Z. Y. Li et al., Coexpression of delta-and mu-opioid receptors in nociceptive sensory neurons, Proc Natl Acad Sci U S A, vol.107, pp.13117-13122, 2010.

J. Wang, C. P. Ding, J. Yu, X. Y. Zeng, S. P. Han et al., Dynamic distributions of tumor necrosis factor-alpha and its receptors in the red nucleus of rats with spared nerve injury, Neuropathology, 2015.

C. P. Watson, R. J. Evans, K. Reed, H. Merskey, L. Goldsmith et al., Amitriptyline versus placebo in postherpetic neuralgia, Neurology, vol.32, pp.671-673, 1982.

A. S. Wattiez, F. Libert, A. M. Privat, S. Loiodice, J. Fialip et al., Evidence for a differential opioidergic involvement in the analgesic effect of antidepressants: prediction for efficacy in animal models of neuropathic pain?, Br J Pharmacol, vol.163, pp.792-803, 2011.

D. F. Welty, G. P. Schielke, M. G. Vartanian, and C. P. Taylor, Gabapentin anticonvulsant action in rats: disequilibrium with peak drug concentrations in plasma and brain microdialysate, Epilepsy Res, vol.16, pp.175-181, 1993.

G. T. Whiteside, A. Adedoyin, and L. Leventhal, Predictive validity of animal pain models? A comparison of the pharmacokinetic-pharmacodynamic relationship for pain drugs in rats and humans, Neuropharmacology, vol.54, pp.767-775, 2008.

R. Wodarski, A. K. Clark, J. Grist, F. Marchand, and M. Malcangio, Gabapentin reverses microglial activation in the spinal cord of streptozotocin-induced diabetic rats, Eur J Pain, vol.13, pp.807-811, 2009.

A. K. Wong, S. Kerkoutian, J. Said, H. Rashidi, and S. T. Pullarkat, Risk of lymphoma in patients receiving antitumor necrosis factor therapy: a meta-analysis of published randomized controlled studies, Clin Rheumatol, vol.31, pp.631-636, 2012.

I. Yalcin, N. Choucair-jaafar, M. Benbouzid, L. H. Tessier, A. Muller et al., )-adrenoceptors are critical for antidepressant treatment of neuropathic pain, Ann Neurol, vol.65, issue.2, pp.218-225, 2009.

I. Yalcin, L. H. Tessier, N. Petit-demouliere, S. Doridot, L. Hein et al., Beta2-adrenoceptors are essential for desipramine, venlafaxine or reboxetine action in neuropathic pain, Neurobiol Dis, vol.33, pp.386-394, 2009.
URL : https://hal.archives-ouvertes.fr/hal-00365807

I. Yalcin, L. H. Tessier, N. Petit-demouliere, E. Waltisperger, L. Hein et al., Chronic treatment with agonists of beta(2)-adrenergic receptors in neuropathic pain, Exp Neurol, vol.221, pp.115-121, 2010.

I. Yalcin, Y. Bohren, E. Waltisperger, D. Sage-ciocca, J. C. Yin et al., A timedependent history of mood disorders in a murine model of neuropathic pain, Biol Psychiatry, vol.70, pp.946-953, 2011.

I. Yalcin, S. Megat, F. Barthas, E. Waltisperger, M. Kremer et al., The sciatic nerve cuffing model of neuropathic pain in mice, J Vis Exp, vol.89, p.51608, 2014.

S. Yamamoto, H. Ono, K. Kume, and M. Ohsawa, Oxaliplatin treatment changes the function of sensory nerves in rats, J Pharmacol Sci, vol.130, pp.189-193, 2016.

R. D. Ye, beta-Adrenergic agonists regulate NF-kappaB activation through multiple mechanisms, Am J Physiol Lung Cell Mol Physiol, vol.279, pp.615-617, 2000.

M. Yoshimura and H. Furue, Mechanisms for the anti-nociceptive actions of the descending noradrenergic and serotonergic systems in the spinal cord, J Pharmacol Sci, vol.101, pp.107-117, 2006.

G. W. Zamponi, J. Striessnig, A. Koschak, and A. C. Dolphin, The Physiology, Pathology, and Pharmacology of Voltage-Gated Calcium Channels and Their Future Therapeutic Potential, Pharmacol Rev, vol.67, pp.821-870, 2015.

J. Zhang, D. Koninck, and Y. , Spatial and temporal relationship between monocyte chemoattractant protein-1 expression and spinal glial activation following peripheral nerve injury, J Neurochem, vol.97, pp.772-783, 2006.

X. Zhao, Y. Xu, Q. Zhao, C. R. Chen, A. M. Liu et al., Curcumin exerts antinociceptive effects in a mouse model of neuropathic pain: descending monoamine system and opioid receptors are differentially involved, Neuropharmacology, vol.62, pp.843-854, 2012.

X. F. Zhou, Y. S. Deng, E. Chie, Q. Xue, J. H. Zhong et al., Satellite-cellderived nerve growth factor and neurotrophin-3 are involved in noradrenergic sprouting in the dorsal root ganglia following peripheral nerve injury in the rat, Eur J Neurosci, vol.11, pp.1711-1722, 1999.

J. Zhu, X. Wei, X. Feng, J. Song, Y. Hu et al., Repeated administration of mirtazapine inhibits development of hyperalgesia/allodynia and activation of NF-kappaB in a rat model of neuropathic pain, Neurosci Lett, vol.433, pp.33-37, 2008.

Y. F. Zhu and J. L. Henry, Excitability of Abeta sensory neurons is altered in an animal model of peripheral neuropathy, BMC Neurosci, vol.13, p.15, 2012.

Y. F. Zhu, Q. Wu, and J. L. Henry, Changes in functional properties of A-type but not C-type sensory neurons in vivo in a rat model of peripheral neuropathy, J Pain Res, vol.5, pp.175-192, 2012.